The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of angiotensin-converting enzyme inhibitors (ACEi) on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
 
Jonathan Thomas
No Relationships to Disclose
 
William Paul Skelton
No Relationships to Disclose
 
Parvaneh Fallah
No Relationships to Disclose
 
Rohit K. Jain
Honoraria - Alphasights (I)
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Pfizer; Seattle Genetics/Astellas; Taiho Oncology (I)
Speakers' Bureau - Gilead Sciences; Seattle Genetics/Astellas
Research Funding - Bristol Myers Squibb
 
Praful Ravi
No Relationships to Disclose
 
Charlene Mantia
Research Funding - Bristol-Myers Squibb (Inst)
 
Bradley Alexander McGregor
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Dendreon; Eisai; EMD Serono; Exelixis; Genentech/Roche; Janssen Oncology; Nextar; Pfizer; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Pfizer/EMD Serono (Inst); Seattle Genetics/Astellas (Inst)
 
Pier Vitale Nuzzo
No Relationships to Disclose
 
Elio Adib
Employment - Amgen (I)
 
Talal El Zarif
No Relationships to Disclose
 
Catherine Curran
Stock and Other Ownership Interests - Alnylam
Research Funding - Alnylam
 
Mark A. Preston
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Research Funding - Merck
Travel, Accommodations, Expenses - Koelis
 
Timothy Nguyen Clinton
No Relationships to Disclose
 
Roger Li
Stock and Other Ownership Interests - crispr therapeutics; Guardant Health
Consulting or Advisory Role - Arquer Diagnostics; Bristol-Myers Squibb; FerGene; Ferring
Research Funding - CG Oncology
Expert Testimony - CG Oncology
Other Relationship - Predicine
 
Graeme S. Steele
No Relationships to Disclose
 
Wassim Kassouf
Consulting or Advisory Role - BMS; Ferring; Janssen; Merck; Roche; Sesen Bio
Research Funding - Roche (Inst); Sesen Bio (Inst)
 
Dory Freeman
No Relationships to Disclose
 
Gregory Russell Pond
Employment - Roche Canada (I)
Stock and Other Ownership Interests - Roche Canada (I)
Honoraria - AstraZeneca; AstraZeneca
Consulting or Advisory Role - Merck; Profound Medical; Takeda
 
Rakesh K. Jain
Leadership - Tekla Capital Management; Tekla Capital Management; Tekla Capital Management; Tekla Capital Management
Stock and Other Ownership Interests - Accurius; Enlight Biosciences; Ophthotech; SynDevRx
Honoraria - Amgen
Consulting or Advisory Role - Accurius; Chugai Pharma USA; Ellipses Pharma; Merck; Ophthotech; Pfizer; PureTech; SPARC; SynDevRx
Research Funding - Boehringer Ingelheim
 
Guru P. Sonpavde
Honoraria - UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; G1 Therapeutics; Genentech; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Loxo/Lilly; Merck; Pfizer; Scholar Rock; Seagen
Speakers' Bureau - Medscape; Onclive; Physicans' Education Resource; Research to Practice
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Janssen (Inst); Predicine (Inst); QED Therapeutics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - Astellas Pharma; AstraZeneca; Bavarian Nordic; Bristol-Myers Squibb; Debiopharm Group; Elsevier; G1 Therapeutics; Mereo BioPharma; QED Therapeutics